The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection

PLoS Pathog. 2017 Jun 29;13(6):e1006342. doi: 10.1371/journal.ppat.1006342. eCollection 2017 Jun.

Author

Andrew Y Koh^{1

2

3}

Affiliations

¹ Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
² Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
³ Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Anti-Bacterial Agents / therapeutic use
Antineoplastic Agents / adverse effects*
Gastrointestinal Microbiome / drug effects
Gastrointestinal Microbiome / physiology*
Hematopoietic Stem Cell Transplantation / adverse effects*
Humans
Immunocompromised Host*
Infections / immunology*
Neoplasms / therapy
Transplant Recipients

Substances

Anti-Bacterial Agents
Antineoplastic Agents

Grants and funding

R01 AI123163/AI/NIAID NIH HHS/United States